Company Data

ADC Therapeutics SA

Ticker
ADCT
Current Price
$2.65 6%
Market Cap
$262.8M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$1.05 - $4.13
Advanced Market Data

Overview

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company’s product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy